Abstract:Inflammatory caspases (caspase-1, -4, -5 and -11) are critical for innate defences. Caspase-1 is activated by ligands of various canonical inflammasomes, and caspase-4, -5 and -11 directly recognize bacterial lipopolysaccharide, both of which trigger pyroptosis. Despite the crucial role in immunity and endotoxic shock, the mechanism for pyroptosis induction by inflammatory caspases is unknown. Here we identify gasdermin D (Gsdmd) by genome-wide clustered regularly interspaced palindromic repeat (CRISPR)-Cas9 nuclease screens of caspase-11- and caspase-1-mediated pyroptosis in mouse bone marrow macrophages. GSDMD-deficient cells resisted the induction of pyroptosis by cytosolic lipopolysaccharide and known canonical inflammasome ligands. Interleukin-1β release was also diminished in Gsdmd−/− cells, despite intact processing by caspase-1. Caspase-1 and caspase-4/5/11 specifically cleaved the linker between the amino-terminal gasdermin-N and carboxy-terminal gasdermin-C domains in GSDMD, which was required and sufficient for pyroptosis. The cleavage released the intramolecular inhibition on the gasdermin-N domain that showed intrinsic pyroptosis-inducing activity. Other gasdermin family members were not cleaved by inflammatory caspases but shared the autoinhibition; gain-of-function mutations in Gsdma3 that cause alopecia and skin defects disrupted the autoinhibition, allowing its gasdermin-N domain to trigger pyroptosis. These findings offer insight into inflammasome-mediated immunity/diseases and also change our understanding of pyroptosis and programmed necrosis.

Gasdermin D triggers cardiolipin-driven mitochondrial damage and pyroptosis

Gasdermin D permeabilization of mitochondrial inner and outer membranes accelerates and enhances pyroptosis

New insights into Gasdermin D pore formation

Gasdermin pores permeabilize mitochondria to augment caspase-3 activation during apoptosis and inflammasome activation

Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores

Gasdermin D in pyroptosis

Pyroptosis: Gasdermin-Mediated Programmed Necrotic Cell Death

Pore-forming activity and structural autoinhibition of the gasdermin family

GSDMD membrane pore formation constitutes the mechanism of pyroptotic cell death

Gasdermin D-mediated pyroptosis: mechanisms, diseases, and inhibitors

Gasdermin D Serves As a Key Executioner of Pyroptosis in Experimental Cerebral Ischemia and Reperfusion Model Both in Vivo and in Vitro.

Structures of the Gasdermin D C-Terminal Domains Reveal Mechanisms of Autoinhibition.

The gasdermin family: emerging therapeutic targets in diseases

Gasdermin D:The killer protein performs cell pyroptosis

GSDMB promotes non-canonical pyroptosis by enhancing caspase-4 activity.

‘Hints’ in the killer protein gasdermin D: unveiling the secrets of gasdermins driving cell death

Molecular and Structural Aspects of Gasdermin Family Pores and Insights into Gasdermin-Elicited Programmed Cell Death

Gasdermin D Mediates Doxorubicin-Induced Cardiomyocyte Pyroptosis and Cardiotoxicity Via Directly Binding to Doxorubicin and Changes in Mitochondrial Damage.

Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death

Downstream of gasdermin D cleavage, a Ragulator-Rag-mTORC1 pathway promotes pore formation and pyroptosis

Pore formation by GSDMD is the effector mechanism of pyroptosis